Microsensor Revolutionizing
Insight into Bladder Function
THE SOLUTION
All-in-one solution for completely new insight
Continuous pressure monitoring based on natural filling of the bladder.
Less than 1 mm MEMS pressure sensor attached to a wire and an external patch containing electronics for data storage and transfer.
The sensor probe (4Fr) is inserted via the suprapubic technique into the bladder and the patch attached to the skin.
High-resolution, accurate and realistic bladder pressure data is sent continuously to the cloud for data analysis.
“Being able to monitor pressure over time-based on natural filling cycles will be a gamechanger in the field of urology.”
- Dr Lennart Wagrell, Renowned Urologist
CLINICAL
Patient Group
Benign Prostatic Hyperplasia
307 Million Worldwide
ENLARGED PROSTATE
The PRESSURO® Benefit
Understand the degree of obstruction
Identify candidates who will benefit from surgery
Prevent bladder collapse
CLINICAL PARTNER
Prof. Dr. med. Jorge Rioja
Focusing on the Benign Prostatic Hyperplasia (BPH) patient group
University of Zaragoza in Spain
For patients with BPH, PRESSURO will provide new insight to those who present with filling symptoms as well as hypotonic bladders. This insight will be used to determine whether surgery is the correct treatment. PRESSURO will provide insight before, during and after treatment.
Urinary Incontinence
423 Million Worldwide
INCONTINENCE
The PRESSURO® Benefit
Understand if the problem originates from urge or stress incontinence
Identify candidates who will benefit from (sling) surgery or medical treatment
CLINICAL PARTNER
Prof. Dr. med. Oliver Hakenberg
Focusing on Neurogenic patient group
Rostock University in Germany
Patients with Spinal Cord Injury, MS, Parkinson’s can develop neurogenic bladders. They are at a higher risk of kidney damage which can be life threatening. PRESSURO can provide up to 30 days of bladder pressure monitoring to help determine further treatments.
Neurogenic bladder
135 Million Worldwide
NEUROGENIC BLADDER
The PRESSURO® Benefit
Prevent kidney failure, a life-threatening condition
Decide on the best treatment
CLINICAL PARTNER
Prof. Dr. med. Oliver Hakenberg
Focusing on Neurogenic patient group
Rostock University in Germany
Patients with Spinal Cord Injury, MS, Parkinson’s can develop neurogenic bladders. They are at a higher risk of kidney damage which can be life threatening. PRESSURO can provide up to 30 days of bladder pressure monitoring to help determine further treatments.
Children with Voiding Problems
20 Million Worldwide
CHILDREN WITH URINARY DYSFUNCTION
The PRESSURO® Benefit
Provide new functional insight that is not available using today’s method
CLINICAL PARTNER
Prof. Dr. med. Jens Rassweiler
Focusing on children suffering from filling and voiding problems
Klinikum Heilbronn, the academic hospital of Heidelberg University
For children, PRESSURO will offer new possibilities of functional insight which has not been available to this group before due to the delicate nature of their developing systems. The goal is to eliminate the trial and error methods of medications and treatments currently used by using our new insight.
PRESSURO®
Network of more than 20 urologists (KOLs) across Europe
More than 20 leading urologists around the world are on the waiting list to use PRESSURO®. We have selected some of the best clinicians to lead our clinical trials.
WHAT THE INDUSTRY IS SAYING
Dr. Glyn Burtt
Former Medical Director at Boston Scientific
Dr. Glyn Burtt, Medical Director at Boston Scientific until recently, is a big fan too. In this video he explains how PRESSURO can help to select the right candidates for the different surgical treatments Boston Scientific offers.